Citations 3
P68 Mirikizumab versus placebo: histologic inflammation in 5 intestinal segments in randomized controlled phase 3 trial for crohn’s disease participants
Feagan, Brian G., Hisamatsu, Tadakazu , D’Haens, Geert , Pai, Rish K. , Lin, Zhantao, Protić, Marijana , Hon, Emily, Escobar, Rodrigo , Reinisch, Walter , Dhesi, Endip , Jairath, Vipul , Magro, Fernando , Hertogh, Gert D. , Harpaz, Noam , Morris, Nathan , Owen, Charles, Reinisch, Walter
Posters | June 23, 2025 | Volume: No volume available | Issue: No issue available | Pages: A129.2-A130
P115 Efficacy of mirikizumab in comparison to ustekinumab in patients with moderate-to-severe Crohn’s disease: results from phase 3 VIVID 1 study
Sands, Bruce E, Ferrante, Marc, Hisamatsu, Tadakazu , Kaser, Arthur , Reinisch, Walter , Bragg, Sonja M., Hon, Emily, Lin, Zhantao, Lopes, Michelle Ugolini, Protić, Marijana , Dhesi, Endip , Jairath, Vipul , Bossuyt, Peter , Farraye, Francis A. , Kierkuś, Jarosław , Laharie, David , Reinisch, Walter , Siegmund, Britta , Morris, Nathan , Danese, Silvio
Poster Presentations | July 1, 2024 | Volume: No volume available | Issue: No issue available | Pages: A120.1-A120
P304 Impact of mirikizumab on histologic measures of intestinal inflammation in a phase 2 study of patients with moderate-severe crohn’s disease
Pai, Rish K. , Reinisch, Walter , Feagan, Brian G. , Agada, Noah , Pollack, Paul, Chan, Lai Shan, Protić, Marijana , Dhesi, Endip , Hertogh, Gert D. , Reinisch, Walter , Harpaz, Noam , Magro, Fernando
Poster presentations | June 18, 2023 | Volume: No volume available | Issue: No issue available | Pages: A210.1-A210